Compare TKO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKO | ELAN |
|---|---|---|
| Founded | 1980 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.4B |
| IPO Year | 2023 | 2018 |
| Metric | TKO | ELAN |
|---|---|---|
| Price | $184.40 | $24.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $224.53 | $27.89 |
| AVG Volume (30 Days) | 1.1M | ★ 7.4M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.70% | N/A |
| EPS Growth | ★ 11200.00 | N/A |
| EPS | ★ 2.46 | 0.22 |
| Revenue | ★ $4,735,151,000.00 | $4,715,000,000.00 |
| Revenue This Year | $23.14 | $8.21 |
| Revenue Next Year | $1.05 | $5.31 |
| P/E Ratio | ★ $74.93 | $111.36 |
| Revenue Growth | ★ 68.85 | 6.22 |
| 52 Week Low | $176.00 | $17.11 |
| 52 Week High | $226.94 | $27.98 |
| Indicator | TKO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 51.00 |
| Support Level | $180.23 | $23.40 |
| Resistance Level | $190.19 | $25.82 |
| Average True Range (ATR) | 5.25 | 0.63 |
| MACD | -1.10 | 0.15 |
| Stochastic Oscillator | 6.27 | 74.14 |
TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.